Sharad P Adekar

Title: Innovations of Sharad P. Adekar

Introduction

Sharad P. Adekar is an accomplished inventor based in Secane, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of hybrid cells that express useful antibodies. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

One of his latest patents is titled "Method of making hybrid cells that express useful antibodies." This invention relates to a novel hybridoma strategy that uses CD27+ B cells cultured in vitro to induce IgM to IgG class switch prior to fusion with a fusion partner. Hybridomas resulting from the fusion between CD27+ B cells and a fusion partner cell line, along with antibodies secreted from the hybridomas, are included in this invention. Another significant patent is "Fusion partner cell line for preparation of hybrid cells expressing human antibodies." This invention describes a novel fusion partner cell line that ectopically expresses IL-6 and TERT, termed B5-6T, and methods for making the B5-6T fusion partner cell line. The B5-6T fusion partner cell line can be fused with B-lymphocytes to generate hybridomas that secrete human monoclonal antibodies.

Career Highlights

Sharad P. Adekar is affiliated with Thomas Jefferson University, where he continues to advance his research in the field of biotechnology. His work is characterized by a commitment to innovation and the development of new methodologies that enhance the production of therapeutic antibodies.

Collaborations

He collaborates with notable professionals in his field, including Scott K. Dessain, which further enriches his research endeavors.

Conclusion

Sharad P. Adekar's contributions to biotechnology through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical therapies.